Marc Goodman

Stock Analyst at Leerink Partners

(2.38)
# 561
Out of 5,311 analysts
141
Total ratings
56.45%
Success rate
26.03%
Average return
40 Stocks
Name Action Price Target Current % Upside Ratings Updated
OPT Opthea
Downgrades: Market Perform
12 1
n/a n/a 2 Mar 25, 2025
AXSM Axsome Therapeutics
Maintains: Outperform
110 150
96.04 56.18% 7 Feb 10, 2025
RLMD Relmada Therapeutics
Downgrades: Market Perform
10 1
0.28 257.14% 3 Dec 4, 2024
BHVN Biohaven
Maintains: Outperform
55 60
17.36 245.62% 6 Sep 23, 2024
LENZ LENZ Therapeutics
Initiates Coverage On: Outperform
32
18.5 72.97% 1 Apr 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Mar 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
56.99 -56.13% 1 Jul 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
1
n/a n/a 5 Mar 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
50
12.36 304.53% 1 Jan 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
27 23
n/a n/a 4 Jan 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
18 20
9.37 113.45% 3 Jan 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
15 1
n/a n/a 4 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
100 115
90.06 27.69% 4 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
270 310
113.5 173.13% 11 Oct 26, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
9 4
n/a n/a 4 Aug 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
6 12
7.18 67.13% 2 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 46
30.11 52.77% 4 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
170 270
n/a n/a 2 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
27 21
13.98 50.21% 5 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
200 210
100.79 108.35% 5 Aug 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
50 40
6.89 480.55% 5 Jul 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 10
1.49 571.14% 2 Jul 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
24 27
26.43 2.16% 5 Apr 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
65 70
n/a n/a 3 Apr 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
10 2
n/a n/a 4 Mar 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 15
1.84 715.22% 2 Dec 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
37 32
n/a n/a 3 Dec 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
322 70
n/a n/a 3 May 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
200 220
n/a n/a 1 Feb 4, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
300 270
352.26 -23.35% 5 Mar 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
79 96
171.22 -43.93% 5 Nov 19, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
189 203
n/a n/a 5 Nov 19, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
72 0
n/a n/a 2 May 21, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Nov 13, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
6 7
n/a n/a 4 Nov 10, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
12 16
n/a n/a 2 Oct 30, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
72 67
77.39 -13.43% 3 Oct 30, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
19 15
n/a n/a 2 Oct 12, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
84 98
24.28 303.62% 3 Oct 5, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Mar 20, 2017